The present disclosure concerns dosages for the treatment of human patients susceptible to or diagnosed with a disease, such as cancer. Provided are methods for administering chimeric antigen receptor (CAR)-T cells. Also provided are compositions and articles of manufacture for use in the methods.本發明係關於用於治療易患或診斷患有諸如癌症疾病之劑量。本發明提供用於投與嵌合抗原受體(chimeric antigen receptor,CAR) -T細胞之方法。本發明亦提供該等方法中所用之組合物及製品。